tiprankstipranks
Holding AU:IXJ?
Track your performance easily

AU:IXJ Price & Analysis

IXJ ETF Chart & Stats

Day’s Range― - ―
52-Week Range119.39 - 142.00
Previous Close138.52
VolumeN/A
Average Volume (3M)13.70K
AUM1.35B
NAV138.77
Expense Ratio0.46%
Holdings CountN/A
Beta0.29
Inception DateNov 13, 2001
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding9,578,931
Standard Deviation0.07
10 Day Avg. Volume16,683
30 Day Avg. Volume13,697
Alpha-0.00158

iShares Global Healthcare ETF CDI (IXJ) Fund Flow Chart

iShares Global Healthcare ETF CDI (IXJ) 1 year Net Flows: -45M

IXJ ETF FAQ

What was AU:IXJ’s price range in the past 12 months?
AU:IXJ lowest ETF price was 119.39 and its highest was 142.00 in the past 12 months.
    What is the AUM of AU:IXJ?
    As of May 16, 2024 The AUM of AU:IXJ is 1.35B.
      Is AU:IXJ overvalued?
      Not enough analysts have published a price target to calculate whether the price is overvalued.
      Does AU:IXJ pay dividends?
      AU:IXJ does not currently pay dividends.
      How many shares outstanding does AU:IXJ have?
      AU:IXJ has 9,578,931 shares outstanding.
        Which hedge fund is a major shareholder of AU:IXJ?
        Currently, no hedge funds are holding shares in AU:IXJ

        ETF Description

        iShares Global Healthcare ETF CDI

        The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks
        Sector
        Sector
        Asset Class
        Equity
        Region
        Global
        Issuer
        iShares
        Index Tracked
        S&P Global 1200 Healthcare Sector Index - AUD
        Ticker Symbol
        AU:IXJ
        Popular ETFs
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis